HB 3344

  • West Virginia House Bill
  • 2025 Regular Session
  • Introduced in House Mar 27, 2025
  • Passed House Mar 26, 2025
  • Senate
  • Governor

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Votes


Actions


Apr 11, 2025

Senate

Laid over on 3rd reading 4/11/2025

Senate

Deferred until foot of 2nd reading

Senate

On 3rd reading

Apr 10, 2025

Senate

On 2nd reading

Senate

Committee amendment adopted (Voice vote)

Senate

Read 2nd time

Apr 09, 2025

Senate

Immediate consideration

Senate

Read 1st time

Senate

Reported do pass

Apr 08, 2025

Senate

To Finance

Senate

Reported do pass, with amendment, but first to Finance

Mar 27, 2025

Senate

Introduced in Senate

Senate

To Health and Human Resources then Finance

Senate

To Health and Human Resources

Mar 26, 2025

House

Communicated to Senate

House

Passed House (Roll No. 198)

House

Read 3rd time

House

On 3rd reading, Special Calendar

Mar 25, 2025

House

On 2nd reading, Special Calendar

House

Read 2nd time

Mar 24, 2025

House

Read 1st time

House

On 1st reading, Special Calendar

Mar 21, 2025

House

Do pass

Mar 18, 2025

House

Markup Discussion

Mar 13, 2025

House

Introduced in House

House

To House Health and Human Resources

House

To Health and Human Resources

House

Filed for introduction

Bill Text

Bill Text Versions Format
Engrossed Version VND.OPENXMLFORMATS-OFFICEDOCUMENT.WORDPROCESSINGML.DOCUMENT PDF HTML
Introduced Version VND.OPENXMLFORMATS-OFFICEDOCUMENT.WORDPROCESSINGML.DOCUMENT PDF HTML
hb3344 s hhr am _1 4-8 adopted.htm HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the West Virginia Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.